These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 7542334)

  • 1. Pharmacological characterization of neuronal acetylcholine gated ion channel receptor-mediated hippocampal norepinephrine and striatal dopamine release from rat brain slices.
    Sacaan AI; Dunlop JL; Lloyd GK
    J Pharmacol Exp Ther; 1995 Jul; 274(1):224-30. PubMed ID: 7542334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterization of SIB-1765F: a novel cholinergic ion channel agonist.
    Sacaan AI; Reid RT; Santori EM; Adams P; Correa LD; Mahaffy LS; Bleicher L; Cosford ND; Stauderman KA; McDonald IA; Rao TS; Lloyd GK
    J Pharmacol Exp Ther; 1997 Jan; 280(1):373-83. PubMed ID: 8996218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (S)-(-)-Cotinine, the major brain metabolite of nicotine, stimulates nicotinic receptors to evoke [3H]dopamine release from rat striatal slices in a calcium-dependent manner.
    Dwoskin LP; Teng L; Buxton ST; Crooks PA
    J Pharmacol Exp Ther; 1999 Mar; 288(3):905-11. PubMed ID: 10027825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release.
    Clarke PB; Reuben M
    Br J Pharmacol; 1996 Feb; 117(4):595-606. PubMed ID: 8646402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine.
    Miller DK; Sumithran SP; Dwoskin LP
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1113-22. PubMed ID: 12183670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization of dopamine, norepinephrine and serotonin release in the rat prefrontal cortex by neuronal nicotinic acetylcholine receptor agonists.
    Rao TS; Correa LD; Adams P; Santori EM; Sacaan AI
    Brain Res; 2003 Nov; 990(1-2):203-8. PubMed ID: 14568345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholinergic modulation of N-methyl-D-aspartate-evoked [3H]norepinephrine release from rat cortical slices.
    Gonzales RA; Roper LC; Westbrook SL
    J Pharmacol Exp Ther; 1993 Jan; 264(1):282-8. PubMed ID: 8423531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotinic-receptor mediation of S(-)nornicotine-evoked -3H-overflow from rat striatal slices preloaded with -3H-dopamine.
    Teng L; Crooks PA; Buxton ST; Dwoskin LP
    J Pharmacol Exp Ther; 1997 Nov; 283(2):778-87. PubMed ID: 9353398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carrier-mediated release of monoamines induced by the nicotinic acetylcholine receptor agonist DMPP.
    Szász BK; Mayer A; Zsilla G; Lendvai B; Vizi ES; Kiss JP
    Neuropharmacology; 2005 Sep; 49(3):400-9. PubMed ID: 15993437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotinic acetylcholine receptor-mediated [3H]dopamine release from hippocampus.
    Cao YJ; Surowy CS; Puttfarcken PS
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1298-304. PubMed ID: 15542623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of (S)-(2)-5-ethynyl-3-(1-methyl-2-pyrrolidinyl)pyridine HCl (SIB-1508Y, Altinicline), a novel nicotinic acetylcholine receptor agonist.
    Rao TS; Adams PB; Correa LD; Santori EM; Sacaan AI; Reid RT; Cosford ND
    Brain Res; 2008 Oct; 1234():16-24. PubMed ID: 18692487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization.
    Arneric SP; Sullivan JP; Briggs CA; Donnelly-Roberts D; Anderson DJ; Raszkiewicz JL; Hughes ML; Cadman ED; Adams P; Garvey DS
    J Pharmacol Exp Ther; 1994 Jul; 270(1):310-8. PubMed ID: 7518514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of lobeline and dimethylphenylpiperazinium iodide (DMPP) on N-methyl-D-aspartate (NMDA)-evoked acetylcholine release in vitro: evidence for a lack of involvement of classical neuronal nicotinic acetylcholine receptors.
    Rao TS; Correa LD; Lloyd GK
    Neuropharmacology; 1997 Jan; 36(1):39-50. PubMed ID: 9144640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indirect modulation by alpha7 nicotinic acetylcholine receptors of noradrenaline release in rat hippocampal slices: interaction with glutamate and GABA systems and effect of nicotine withdrawal.
    Barik J; Wonnacott S
    Mol Pharmacol; 2006 Feb; 69(2):618-28. PubMed ID: 16269536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive feedback modulation of acetylcholine release from isolated rat superior cervical ganglion.
    Liang SD; Vizi ES
    J Pharmacol Exp Ther; 1997 Feb; 280(2):650-5. PubMed ID: 9023275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand specificity of nicotinic acetylcholine receptors in rat spinal cord: studies with nicotine and cytisine.
    Khan IM; Yaksh TL; Taylor P
    J Pharmacol Exp Ther; 1994 Jul; 270(1):159-66. PubMed ID: 8035312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-n-alkylpyridinium analogs, a novel class of nicotinic receptor antagonists: selective inhibition of nicotine-evoked [3H] dopamine overflow from superfused rat striatal slices.
    Grinevich VP; Crooks PA; Sumithran SP; Haubner AJ; Ayers JT; Dwoskin LP
    J Pharmacol Exp Ther; 2003 Sep; 306(3):1011-20. PubMed ID: 12766255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lobeline and nicotine evoke [3H]overflow from rat striatal slices preloaded with [3H]dopamine: differential inhibition of synaptosomal and vesicular [3H]dopamine uptake.
    Teng L; Crooks PA; Sonsalla PK; Dwoskin LP
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1432-44. PubMed ID: 9067333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent nicotinic blockade by chlorisondamine of noradrenergic neurons in rat brain and cultured PC12 cells.
    Reuben M; Louis M; Clarke PB
    Br J Pharmacol; 1998 Nov; 125(6):1218-27. PubMed ID: 9863650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of nicotinic receptor-mediated release of dopamine from striatal synaptosomes by chlorisondamine and other nicotinic antagonists administered in vitro.
    el-Bizri H; Clarke PB
    Br J Pharmacol; 1994 Feb; 111(2):406-13. PubMed ID: 8004384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.